Marra David E 4

What Happened
David E. Marra, EVP and Chief Underwriting Officer of RenaissanceRe Holdings Ltd. (RNR), received two equity awards on March 1, 2026: 2,975 restricted common shares (grant) and 8,926 performance-based restricted common shares (award), each acquired at $0.00 (restricted grants). On the same date, 953 shares were withheld to satisfy tax withholding obligations related to prior restricted-share vestings — 254, 317 and 382 shares — each withheld at a per-share value of $302.46, totaling $288,245. The grants are reported as Award/Grant (code A) and the share dispositions are reporting-code F (payment of tax liability via share withholding).

Key Details

• Transaction date: March 1, 2026; Form 4 filed March 3, 2026 (timely filing).
• Grants: 2,975 restricted shares (acquired $0.00) and 8,926 performance-based restricted shares (acquired $0.00).
• Withheld shares for taxes: 254 shares ($76,825), 317 shares ($95,880), 382 shares ($115,540); total withheld = 953 shares / ~$288,245 at $302.46 per share.
• Shares owned after the transactions: not specified in the filing.
• Relevant footnotes:
  • F1: 2,975 restricted shares vest in four equal annual installments beginning March 1, 2027.
  • F2: 8,926 performance-based restricted shares represent the maximum possible award; vesting after service period (12/31/2028) depends on performance and continued employment.
  • F3–F5: the withheld shares relate to withholding taxes upon vesting of restricted shares granted on March 1 of 2023, 2024 and 2025.
• Transaction types explained: A = award/grant (restricted shares); F = shares withheld to satisfy tax liabilities (not an open-market sale).

Context

• The grants are equity compensation (restricted and performance-based) and do not represent an open-market purchase or sale by the insider. Performance shares are contingent on future metrics and continued service, so the full 8,926 may not ultimately vest.
• The withheld shares are routine tax-withholding actions tied to vesting events and are different from discretionary insider sales.
• No indication of a 10b5-1 plan, gifts, or option exercises in this filing.